RPC Acquires Peracidin Product Line from Angelini Pharma

Angelini Pharma Acquires Catalyst Pharmaceuticals

May 7, 2026

Healthcare Services

Angelini Pharma S.p.A. completed its acquisition of Catalyst Pharmaceuticals, Inc. for an aggregate equity value of approximately $4.1 billion (about €3.5 billion), giving Angelini ownership of Catalyst’s product portfolio and commercial infrastructure. The transaction included participation from funds managed by Blackstone and a €1 billion capital increase approved by CDP Equity, and is part of Angelini Pharma’s expansion into the U.S. brain health and rare disease market.

PAI Pharma Acquires Nivagen Pharmaceuticals

January 8, 2026

Healthcare Services

PAI Pharma, an Olympus Partners portfolio company, acquired Nivagen Pharmaceuticals to expand domestic aseptic sterile injectable manufacturing capacity and accelerate development of ready-to-use (RTU) injectable products for hospitals. The deal adds a newly built state-of-the-art aseptic facility in Sacramento, California, and brings a pipeline of more than 20 RTU sterile injectable products.

Altaris Capital Partners Acquires Perrigo's Prescription Pharmaceuticals Business (Padagis)

March 1, 2021

Pharmaceuticals

Altaris Capital Partners has acquired Perrigo's prescription pharmaceuticals business for $1.55 billion and completed the carve-out, renaming the business Padagis. The business, a leader in generic prescription pharmaceuticals with more than 1,300 employees across six U.S. and Israeli locations and a portfolio of 200+ product families (800 SKUs), will be headquartered in the United States as a standalone company.

Pharmaron Acquires Absorption Systems

November 9, 2020

Healthcare Services

Pharmaron Beijing Co., Limited acquired 100% of Absorption Systems for up to US$137.5 million in cash. The purchase brings Absorption Systems’ non-clinical DMPK/ADME and bioanalysis capabilities and U.S. lab footprint (Philadelphia, San Diego and Boston) into Pharmaron’s integrated drug R&D services platform to expand capabilities and U.S. presence.

Evonik Industries Acquires PeroxyChem from One Equity Partners for $640 Million

February 3, 2020

Manufacturing

Evonik Industries AG has completed the acquisition of PeroxyChem, LLC, a global manufacturer of hydrogen peroxide and peracetic acid, from One Equity Partners for $640 million. The purchase, representing roughly a 9.9x multiple of EBITDA, expands Evonik's specialty chemicals portfolio and brings PeroxyChem's production footprint and technical capabilities into Evonik's global operations.

Palladium Equity Partners Acquires Accupac, Inc.

January 22, 2020

Manufacturing

Palladium Equity Partners has acquired Accupac, Inc., a U.S.-based contract manufacturer and packager of personal care and beauty products, from J.H. Whitney Capital Partners. Accupac operates FDA-registered, cGMP-compliant facilities in Mainland, Pennsylvania and Lakewood, New Jersey, employs roughly 600 people and generated over $200 million in revenue in 2019; Palladium says it will support growth through product innovation, new account penetration and M&A.